Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
about
Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solutionClinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophyUltra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.Vaginal rugation rejuvenation (restoration): a new surgical technique for an acquired sensation of wide/smooth vagina.Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopauseTreatment of the genitourinary syndrome of menopause.An update on drugs for the treatment of menopausal symptoms.Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal WomenUltra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy.Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study.Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease.Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy.Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.Pharmacologic evaluation of ospemifene.Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.Profile of ospemifene in the breast.Assessment of vaginal atrophy: a review.Vaginal oestrogen for overactive bladder in post-menopausal women.Oestrogen replacement in postmenopausal women.The role of local estrogen therapy in the management of pelvic floor disorders.Factors associated with reporting classic menopausal symptoms differ.Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women.Pelvic floor muscle activity, quality of life, and sexual function in peri- and recently postmenopausal women with and without dyspareunia: a cross-sectional study.Effect of Foeniculum vulgare (fennel) on vaginal atrophy in postmenopausal women: A double-blind, randomized, placebo-controlled trial.Treatment with oestrogen or manual separation for labial adhesions - initial outcome and long-term follow-up.Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
P2860
Q27025094-AEA2C565-A583-4471-BECC-B427CB50C853Q28066699-8E5BB88E-8422-45D4-939D-E1361FCFB061Q33628455-5C08417D-BB34-4BA5-97E2-B01089348751Q33858050-7BEC6682-1EC8-40F5-912F-767FB2C91047Q33987279-4EB70B5A-197D-4673-9F98-EC18EA43B4BBQ34108946-5554F43D-8F82-45D1-8FBE-1EED1BEFA90CQ34532021-3102E23D-2626-4A7C-A5F0-008E5FD70FF7Q35772318-0315EC87-8440-48DA-86AE-2CEF38E3F171Q35784054-E63F48AA-CA86-4113-8DB2-0B250D631F90Q37102836-39BA50CE-E7A3-4064-8683-94239A94A8DBQ37206316-45E9291F-28E6-486F-BEC5-B856FEC52DC2Q37567415-8AAB502C-909C-41B1-9BD5-151DB7D739F4Q37610413-E6C0B639-85C2-41D9-987C-3C3235A3B1BEQ37611334-4C5CF053-CE2E-4149-B332-5AC0FB147C8DQ37644620-387F1A90-E949-4FA5-AFC3-8FBEF6671343Q37677579-3F749BC4-4DCC-4F1D-BAC0-2F359DA51CB7Q37739433-9A846118-D2FD-4AB6-9C57-5BF283E136BAQ38065195-093EB76A-CEF1-4117-B104-E6F935BA85F9Q38129004-0B191223-85E3-4570-94DF-B54304E2D3C3Q38232359-BB56652E-0F4F-4A15-AEFF-CCF39C015DD1Q38525693-78DF76B7-880B-4F45-8E06-A2350C787499Q38526762-6D01184F-36BD-4DB3-836A-211201FEBF9AQ38717871-B153C602-4EB6-415F-895A-7DAC7FA4AB10Q44212903-41419479-64B0-44E0-9B7F-6DCF03CD64F1Q45898328-8AA7A49C-600E-4DD0-8E0B-F46BE18A7D46Q47823176-BBBE2A33-207B-4DAA-BE41-A7176BE856C8Q48128578-A984CF74-77F2-4871-BC60-4343BE373E92Q49486677-B6DFD46B-3787-4F4A-B295-443CECC0A1DFQ52666169-EE904D76-ECC3-4FFE-BA85-F94E62CB10B1Q53237423-F7D2C28F-0A2E-4F84-91D6-301B0189B17C
P2860
Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@en
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@nl
type
label
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@en
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@nl
prefLabel
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@en
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@nl
P2860
P1433
P1476
Topical estrogen therapy in th ...... rophy: an up-to-date overview.
@en
P2093
A A A Ewies
O Al-Baghdadi
P2860
P304
P356
10.1080/13697130802585576
P577
2009-04-01T00:00:00Z